High expression of ERα36 has been observed in breast cancer stem cells18–21, ER-positive and -negative human breast carcinomas22, endometrial carcinomas23 and gastric carcinomas24, which has shown to be associated with malignancy, invasion, metastasis, resistance to treatment and poor prognosis in these types of carcinomas. Here, ESR1 is linked to breast carcinoma.